Patents by Inventor Carol Tan

Carol Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11390922
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
    Type: Grant
    Filed: May 25, 2018
    Date of Patent: July 19, 2022
    Assignee: University of Chicago
    Inventors: Ravi Salgia, Soundarajan Krishnaswamy, Yi-Hung Carol Tan, Suvobroto Nandi
  • Publication number: 20180327864
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
    Type: Application
    Filed: May 25, 2018
    Publication date: November 15, 2018
    Inventors: Ravi Salgia, Soundarajan Krishnaswamy, Yi-Hung Carol Tan, Suvobroto Nandi
  • Publication number: 20180112270
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
    Type: Application
    Filed: March 22, 2016
    Publication date: April 26, 2018
    Inventors: Ravi Salgia, Soundarajan Krishnaswamy, Yi-Hung Carol Tan, Suvobroto Nandi
  • Publication number: 20130217012
    Abstract: The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
    Type: Application
    Filed: June 3, 2011
    Publication date: August 22, 2013
    Inventors: Ravi Salgia, Soundarajan Krishnaswamy, Yi-Hung Carol Tan, Suvobroto Nandi
  • Publication number: 20120258890
    Abstract: The present application describes methods for assessing influenza infection, including prognosis. An assay that determines the amount of the NS1 and NP proteins of influenza virus shows enhanced sensitivity and reliability compared to either antigen alone. Many formats employ pan-specific antibodies (i.e., that react with all or at least with multiple strains within an influenza type).
    Type: Application
    Filed: April 4, 2012
    Publication date: October 11, 2012
    Applicant: ARBOR VITA CORPORATION
    Inventors: PETER S. LU, MICHAEL P. BELMARES, CAROL TAN, LINDA MCALLISTER
  • Patent number: 8163474
    Abstract: The present application describes methods for assessing influenza infection, including prognosis. An assay that determines the amount of the NS1 and NP proteins of influenza virus shows enhanced sensitivity and reliability compared to either antigen alone. Many formats employ pan-specific antibodies (i.e., that react with all or at least with multiple strains within an influenza type).
    Type: Grant
    Filed: March 16, 2009
    Date of Patent: April 24, 2012
    Assignee: Arbor Vita Corporation
    Inventors: Peter S. Lu, Michael P. Belmares, Carol Tan, Linda McAllister
  • Publication number: 20090280504
    Abstract: The present application describes methods for assessing influenza infection, including prognosis. An assay that determines the amount of the NS1 and NP proteins of influenza virus shows enhanced sensitivity and reliability compared to either antigen alone. Many formats employ pan-specific antibodies (i.e., that react with all or at least with multiple strains within an influenza type).
    Type: Application
    Filed: March 16, 2009
    Publication date: November 12, 2009
    Applicant: ARBOR VITA CORPORATION
    Inventors: PETER S. LU, MICHAEL P. BELMARES, CAROL TAN, LINDA MCALLISTER
  • Publication number: 20090233380
    Abstract: The present application describes methods for conjugating gold to biological molecules and conjugates resulting from the same. The method provides superior gold conjugated biomolecules with higher sensitivity than those made from conventional gold conjugation methods.
    Type: Application
    Filed: January 23, 2009
    Publication date: September 17, 2009
    Applicant: Arbor Vita Corporation
    Inventors: Michael Belmares, Carol Tan, Lilyn Liu